JD Health announced that its board of directors will convene on 13 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend for shareholders.
Management will host an earnings call on the same day at 17:00 (Beijing/Hong Kong Time) to present the half-year performance and respond to investor questions. Dial-in access will be available for participants in Mainland China, Hong Kong, the United States and Singapore, with separate passcodes for Mandarin and English channels.
The board currently comprises one executive director, one non-executive director and five independent non-executive directors. The announcement was issued in Hong Kong on 31 July 2026 and signed by Executive Director Mr. Dong Cao.
Comments